Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

Equality Impact Assessment (Guidance development) (PDF 154 KB)

Final draft guidance

Final draft guidance (PDF 130 KB)

Final draft guidance Equality Impact Assessment (PDF 154 KB)

Committee papers updated post-appeal period (PDF 5.36 MB)

Final scope updated June 2023 (PDF 181 KB)

Final stakeholder list updated June 2023 (PDF 171 KB)

Draft guidance

Appraisal consultation document (PDF version) (PDF 292 KB)

Committee papers (PDF 6.31 MB)

Public committee slides (PDF 1.51 MB)

Appraisal consultation document (online commenting)

Appraisal consultation document (PDF version) Equality Impact Assessment (EIA) (PDF 153 KB)

Committee meeting

Supporting documentation Register of Interests (PDF 297 KB)

Final scope (PDF 178 KB)

Final stakeholder list (PDF 164 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 488 KB)

Equality impact assessment (Scoping) (PDF 129 KB)

Draft scope post referral (PDF 193 KB)

Draft matrix post referral (PDF 164 KB)